391 related articles for article (PubMed ID: 32594276)
1. Long non-coding RNA: A recently accentuated molecule in chemoresistance in cancer.
Peng Y; Tang D; Zhao M; Kajiyama H; Kikkawa F; Kondo Y
Cancer Metastasis Rev; 2020 Sep; 39(3):825-835. PubMed ID: 32594276
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs in cancer drug resistance development.
Majidinia M; Yousefi B
DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in the doxorubicin resistance of cancer cells.
Ashrafizaveh S; Ashrafizadeh M; Zarrabi A; Husmandi K; Zabolian A; Shahinozzaman M; Aref AR; Hamblin MR; Nabavi N; Crea F; Wang Y; Ahn KS
Cancer Lett; 2021 Jun; 508():104-114. PubMed ID: 33766750
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
5. Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH; Chen Y
Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
[TBL] [Abstract][Full Text] [Related]
6. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
Jin KT; Lu ZB; Lv JQ; Zhang JG
RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
[TBL] [Abstract][Full Text] [Related]
7. Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm.
Zhang J; Wu L; Wang C; Xie X; Han Y
Drug Des Devel Ther; 2024; 18():1385-1398. PubMed ID: 38689609
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
Abu N; Hon KW; Jeyaraman S; Jamal R
Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
[TBL] [Abstract][Full Text] [Related]
11. The functional roles of exosomal long non-coding RNAs in cancer.
Wang M; Zhou L; Yu F; Zhang Y; Li P; Wang K
Cell Mol Life Sci; 2019 Jun; 76(11):2059-2076. PubMed ID: 30683984
[TBL] [Abstract][Full Text] [Related]
12. Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data.
Gao Y; Shang S; Guo S; Li X; Zhou H; Liu H; Sun Y; Wang J; Wang P; Zhi H; Li X; Ning S; Zhang Y
Nucleic Acids Res; 2021 Jan; 49(D1):D1251-D1258. PubMed ID: 33219685
[TBL] [Abstract][Full Text] [Related]
13. Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance.
Nandi S; Mondal A; Ghosh A; Mukherjee S; Das C
Adv Cancer Res; 2023; 160():133-203. PubMed ID: 37704287
[TBL] [Abstract][Full Text] [Related]
14. Systematic identification of dysregulated lncRNAs associated with platinum-based chemotherapy response across 11 cancer types.
Zhu Y; Zhao Y; Dong S; Liu L; Tai L; Xu Y
Genomics; 2020 Mar; 112(2):1214-1222. PubMed ID: 31302201
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA mediated drug resistance in breast cancer.
Singh D; Assaraf YG; Gacche RN
Drug Resist Updat; 2022 Jul; 63():100851. PubMed ID: 35810716
[TBL] [Abstract][Full Text] [Related]
16. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs regulate drug resistance in cancer.
Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA GHET1 in human cancer.
Li J; Jiang X; Li Z; Huang L; Zhou Y; Liu Y; Cui Y
Clin Chim Acta; 2019 Jan; 488():111-115. PubMed ID: 30399371
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
[TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
